Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lexaria Bioscience (LEXX) Return on Assets (2017 - 2026)

Lexaria Bioscience's Return on Assets history spans 10 years, with the latest figure at 1.51% for Q1 2026.

  • Quarterly results put Return on Assets at 1.51% for Q1 2026, down 49.0% from a year ago — trailing twelve months through Feb 2026 was 1.51% (down 49.0% YoY), and the annual figure for FY2025 was 1.82%, down 86.0%.
  • Return on Assets for Q1 2026 was 1.51% at Lexaria Bioscience, up from 2.1% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.3% in Q1 2022 to a low of 76.02% in Q1 2024.
  • The 5-year median for Return on Assets is 1.6% (2022), against an average of 9.03%.
  • The sharpest move saw Return on Assets tumbled -7219bps in 2024, then soared 7501bps in 2025.
  • Year by year, Return on Assets stood at 1.6% in 2022, then crashed by -137bps to 3.78% in 2023, then surged by 79bps to 0.78% in 2024, then plummeted by -169bps to 2.1% in 2025, then grew by 28bps to 1.51% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 1.51%, 2.1%, and 2.18% for Q1 2026, Q4 2025, and Q3 2025 respectively.